Cargando…
The clinical relevance of omega-3 fatty acids in the management of hypertriglyceridemia
Hypertriglyceridemia (triglycerides > 150 mg/dL) affects ~25 % of the United States (US) population and is associated with increased cardiovascular risk. Severe hypertriglyceridemia (≥ 500 mg/dL) is also a risk factor for pancreatitis. Three omega-3 fatty acid (OM3FA) prescription formulations ar...
Autores principales: | Backes, James, Anzalone, Deborah, Hilleman, Daniel, Catini, Julia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4957330/ https://www.ncbi.nlm.nih.gov/pubmed/27444154 http://dx.doi.org/10.1186/s12944-016-0286-4 |
Ejemplares similares
-
Update on the management of severe hypertriglyceridemia – focus on free fatty acid forms of omega-3
por: Pirillo, Angela, et al.
Publicado: (2015) -
A Review of Clinical Practice Guidelines for the Management of Hypertriglyceridemia: A Focus on High Dose Omega-3 Fatty Acids
por: Karalis, Dean G.
Publicado: (2016) -
Critical Differences Between Dietary Supplement and Prescription Omega-3 Fatty Acids: A Narrative Review
por: Hilleman, Daniel E., et al.
Publicado: (2020) -
Effects of Omega-3 Fatty Acid Supplementation on Diabetic Nephropathy Progression in Patients with Diabetes and Hypertriglyceridemia
por: Han, Eugene, et al.
Publicado: (2016) -
Treatment of Severe Hypertriglyceridemia During Pregnancy With High Doses of Omega-3 Fatty Acid and Plasmapheresis
por: Nguyen, Nguyen T., et al.
Publicado: (2021)